Polymer Capital Management (HK)’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.06M Buy
54,100
+10,000
+23% +$421K 0.2% 85
2026
Q2
$2.07M Buy
+44,100
New +$1.09M 0.11% 88
2024
Q2
– Sell
-11,926
Closed -$112K – 213
2024
Q1
$112K Buy
+11,926
New +$68K 0.03% 172

Other funds holding DFTX

Polymer Capital Management (HK)'s DFTX Position: Q3 2026 in Review

Polymer Capital Management (HK) increased its Definium Therapeutics (DFTX) stake by 23% in Q3 2026, buying an estimated $421K and bringing the position to 54,100 shares worth $2.06M. The position accounts for 0.2% of the portfolio, ranked #85.

Polymer Capital Management (HK) first reported a position in DFTX in Q1 2024 and has held it in 3 quarters since. The position peaked at $2.07M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Polymer Capital Management (HK) held 54,100 shares of Definium Therapeutics worth $2.06M as of Q3 2026.
  • Polymer Capital Management (HK) bought 10,000 Definium Therapeutics shares in Q3 2026, an estimated $421K.
  • Definium Therapeutics made up 0.2% of Polymer Capital Management (HK)'s portfolio in Q3 2026, its #85 holding.
  • Polymer Capital Management (HK) first reported a position in Definium Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Polymer Capital Management (HK)'s Definium Therapeutics position peaked at $2.07M in Q2 2026.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Polymer Capital Management (HK)'s 13F filing for Q3 2026, filed 13 Nov 2026.